Best Cardiologists for CRT And CRT-D Device Implantation in India

Heart failure occurs when the heart cannot pump or fill with blood effectively enough to sustain normal bodily function, causing fluid to back up into the lungs or body tissues. It is not a single disease but a clinical syndrome with multiple underlying causes and varying degrees of severity.

Common symptoms include breathlessness at rest or on exertion, persistent fatigue, swelling of the legs and ankles, rapid or irregular heartbeat, and difficulty lying flat due to breathing discomfort. In more advanced cases, people may experience sudden weight gain from fluid retention, reduced ability to exercise, and episodes of severe breathlessness at night. These symptoms can overlap with many other conditions, so their presence alone is not sufficient to establish a diagnosis of heart failure.

Heart failure is typically assessed using a combination of clinical history, physical examination, blood tests (including natriuretic peptide levels such as BNP or NT-proBNP), a 12-lead electrocardiogram, and echocardiography to measure heart structure and pumping function. The ejection fraction — a key measure of how much blood the left ventricle pumps with each beat — is central to classification: heart failure may be categorised as HFrEF (reduced ejection fraction, generally below 40%), HFmrEF (mildly reduced, 40–49%), or HFpEF (preserved ejection fraction, 50% or above). Additional investigations such as cardiac MRI, coronary angiography, or exercise stress testing may be requested depending on the suspected underlying cause and the individual's overall clinical picture.

Treatment for heart failure is tailored to the underlying cause, ejection fraction category, symptom severity, and the presence of complications such as arrhythmias or valve disease. For many patients, a combination of guideline-directed medical therapy and lifestyle changes forms the cornerstone of long-term management, while others may require device-based or surgical interventions. Procedures available for eligible patients include implantable cardioverter-defibrillator (ICD) implantation, cardiac resynchronisation therapy (CRT or CRT-D) to improve the heart's coordination, left ventricular assist device (LVAD) implantation as a bridge to transplant or as destination therapy, and heart transplantation for carefully selected patients with end-stage disease.

For most patients, non-procedural management is the primary or initial approach and includes evidence-based medications — such as ACE inhibitors, ARNIs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors — alongside dietary sodium and fluid restriction, graded physical activity or cardiac rehabilitation, and close monitoring of weight and symptoms. Regular follow-up is critical because heart failure is a dynamic condition that may require adjustments to therapy over time. Non-surgical management alone may not be sufficient for patients with severely reduced heart function, refractory symptoms, or life-threatening arrhythmias, in which case procedural options are evaluated.

CRT and CRT-D Device Implantation may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Heart failure is typically managed by a cardiologist with expertise in heart failure and advanced cardiac therapies, often working within a multidisciplinary team. For patients requiring device implantation, surgical intervention, or transplant evaluation, a cardiothoracic and vascular surgeon with relevant experience in these procedures will also be involved in care planning.

When comparing clinicians or centres for heart failure care, it is worth looking at the specialist's experience with your specific ejection fraction category and any coexisting conditions, the centre's access to advanced therapies such as LVAD programmes and transplant services, and whether a dedicated heart failure multidisciplinary team is in place to coordinate ongoing monitoring and follow-up.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.